Literature DB >> 30036036

Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).

Lindsay P Cameron1, David E Olson2,3,4.   

Abstract

Though relatively obscure, N, N-dimethyltryptamine (DMT) is an important molecule in psychopharmacology as it is the archetype for all indole-containing serotonergic psychedelics. Its structure can be found embedded within those of better-known molecules such as lysergic acid diethylamide (LSD) and psilocybin. Unlike the latter two compounds, DMT is ubiquitous, being produced by a wide variety of plant and animal species. It is one of the principal psychoactive components of ayahuasca, a tisane made from various plant sources that has been used for centuries. Furthermore, DMT is one of the few psychedelic compounds produced endogenously by mammals, and its biological function in human physiology remains a mystery. In this review, we cover the synthesis of DMT as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss the history of DMT in chemical neuroscience and why this underappreciated molecule is so important to the field of psychedelic science.

Entities:  

Keywords:  DMT; N,N-Dimethyltryptamine; ayahuasca; hallucinogen; psychedelic

Mesh:

Substances:

Year:  2018        PMID: 30036036     DOI: 10.1021/acschemneuro.8b00101

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  18 in total

1.  [Ayahuasca-induced psychosis in a patient with bipolar disorder].

Authors:  Nicolas Zellner; Tobias Zellner; Jan Warninghoff
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

2.  Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

Review 3.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

Review 4.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

5.  Psychedelic Microdosing: Prevalence and Subjective Effects.

Authors:  Lindsay P Cameron; Angela Nazarian; David E Olson
Journal:  J Psychoactive Drugs       Date:  2020-01-23

6.  Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Authors:  Calvin Ly; Alexandra C Greb; Maxemiliano V Vargas; Whitney C Duim; Ana Cristina G Grodzki; Pamela J Lein; David E Olson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-09-11

7.  Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics.

Authors:  David E Olson
Journal:  J Exp Neurosci       Date:  2018-09-19

8.  Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.

Authors:  Lindsay P Cameron; Charlie J Benson; Brian C DeFelice; Oliver Fiehn; David E Olson
Journal:  ACS Chem Neurosci       Date:  2019-03-04       Impact factor: 4.418

Review 9.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

10.  Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies.

Authors:  Lee E Dunlap; Arya Azinfar; Calvin Ly; Lindsay P Cameron; Jayashri Viswanathan; Robert J Tombari; Douglas Myers-Turnbull; Jack C Taylor; Ana Cristina Grodzki; Pamela J Lein; David Kokel; David E Olson
Journal:  J Med Chem       Date:  2020-01-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.